Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

A Novel, Rapid, and Low-Volume Assay for Therapeutic Drug Monitoring of Posaconazole and Other Long-Chain Azole-Class Antifungal Drugs.

Wiedman GR, Zhao Y, Perlin DS.

mSphere. 2018 Dec 19;3(6). pii: e00623-18. doi: 10.1128/mSphere.00623-18.

2.

Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.

Hou X, Lee A, Jiménez-Ortigosa C, Kordalewska M, Perlin DS, Zhao Y.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01811-18. doi: 10.1128/AAC.01811-18. Print 2019 Jan.

PMID:
30397051
3.

Spontaneous Mutational Frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata.

Shields RK, Kline EG, Healey KR, Kordalewska M, Perlin DS, Nguyen MH, Clancy CJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01692-18. doi: 10.1128/AAC.01692-18. Print 2019 Jan.

PMID:
30373796
4.

Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay.

Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01337-18. doi: 10.1128/JCM.01337-18. Print 2018 Dec.

PMID:
30232130
5.

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata.

Healey KR, Perlin DS.

J Fungi (Basel). 2018 Sep 1;4(3). pii: E105. doi: 10.3390/jof4030105. Review.

6.

Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.

Vickers CF, Silva APG, Chakraborty A, Fernandez P, Kurepina N, Saville C, Naranjo Y, Pons M, Schnettger LS, Gutierrez MG, Park S, Kreiswith BN, Perlin DS, Thomas EJ, Cavet JS, Tabernero L.

J Med Chem. 2018 Sep 27;61(18):8337-8352. doi: 10.1021/acs.jmedchem.8b00832. Epub 2018 Sep 10.

PMID:
30153005
7.

Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility.

Healey KR, Kordalewska M, Jiménez Ortigosa C, Singh A, Berrío I, Chowdhary A, Perlin DS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01427-18. doi: 10.1128/AAC.01427-18. Print 2018 Oct.

8.

Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes.

Byun SA, Won EJ, Kim MN, Lee WG, Lee K, Lee HS, Uh Y, Healey KR, Perlin DS, Choi MJ, Kim SH, Shin JH.

Front Microbiol. 2018 Jul 13;9:1523. doi: 10.3389/fmicb.2018.01523. eCollection 2018.

9.

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis.

Zhao Y, Lee MH, Paderu P, Lee A, Jimenez-Ortigosa C, Park S, Mansbach RS, Shaw KJ, Perlin DS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00425-18. doi: 10.1128/AAC.00425-18. Print 2018 Oct.

10.

Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar.

Taj-Aldeen SJ, Salah H, Perez WB, Almaslamani M, Motyl M, AbdulWahab A, Healey KR, Perlin DS.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00214-18. doi: 10.1128/AAC.00214-18. Print 2018 Sep.

PMID:
29941644
11.

VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.

Break TJ, Desai JV, Healey KR, Natarajan M, Ferre EMN, Henderson C, Zelazny A, Siebenlist U, Yates CM, Cohen OJ, Schotzinger RJ, Perlin DS, Garvey EP, Lionakis MS.

J Antimicrob Chemother. 2018 Aug 1;73(8):2089-2094. doi: 10.1093/jac/dky170.

PMID:
29788070
12.

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.

Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00238-18. doi: 10.1128/AAC.00238-18. Print 2018 Jun.

13.

Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.

Singh A, Healey KR, Yadav P, Upadhyaya G, Sachdeva N, Sarma S, Kumar A, Tarai B, Perlin DS, Chowdhary A.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00195-18. doi: 10.1128/AAC.00195-18. Print 2018 Jun.

14.

Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling".

Yang F, Zhang L, Wakabayashi H, Myers J, Jiang Y, Cao Y, Jimenez-Ortigosa C, Perlin DS, Rustchenko E.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e00386-18. doi: 10.1128/AAC.00386-18. Print 2018 Apr. No abstract available.

15.

Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens.

Hover BM, Kim SH, Katz M, Charlop-Powers Z, Owen JG, Ternei MA, Maniko J, Estrela AB, Molina H, Park S, Perlin DS, Brady SF.

Nat Microbiol. 2018 Apr;3(4):415-422. doi: 10.1038/s41564-018-0110-1. Epub 2018 Feb 12.

16.

An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds.

Vila-Farres X, Chu J, Ternei MA, Lemetre C, Park S, Perlin DS, Brady SF.

mSphere. 2018 Jan 24;3(1). pii: e00528-17. doi: 10.1128/mSphere.00528-17. eCollection 2018 Jan-Feb.

17.

Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients.

Zhao Y, Nagasaki Y, Paderu P, Sugrue MW, Leather HL, Wingard JR, Perlin DS.

Med Mycol. 2019 Jan 1;57(1):38-44. doi: 10.1093/mmy/myx164.

PMID:
29370415
18.

FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility.

Suwunnakorn S, Wakabayashi H, Kordalewska M, Perlin DS, Rustchenko E.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02299-17. doi: 10.1128/AAC.02299-17. Print 2018 Apr.

19.

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.

Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF.

J Antimicrob Chemother. 2018 Apr 1;73(4):891-899. doi: 10.1093/jac/dkx480.

PMID:
29325167
20.

A novel, tomographic imaging probe for rapid diagnosis of fungal keratitis.

Lee MH, Wiedman G, Park S, Mustaev A, Zhao Y, Perlin DS.

Med Mycol. 2018 Oct 1;56(7):796-802. doi: 10.1093/mmy/myx125.

21.

Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia.

Berrio I, Maldonado N, De Bedout C, Arango K, Cano LE, Valencia Y, Jiménez-Ortigosa C, Perlin DS, Gómez BL, Robledo C, Robledo J; Grupo GERMEN.

J Glob Antimicrob Resist. 2018 Jun;13:254-260. doi: 10.1016/j.jgar.2017.11.010. Epub 2017 Nov 26.

PMID:
29183771
22.

The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.

Healey KR, Nagasaki Y, Zimmerman M, Kordalewska M, Park S, Zhao Y, Perlin DS.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01412-17. doi: 10.1128/AAC.01412-17. Print 2017 Dec.

23.

Emergence of Echinocandin Resistance Due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.

Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01277-17. doi: 10.1128/AAC.01277-17. Print 2017 Dec.

24.

Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.

Perlin DS, Wiederhold NP.

J Infect Dis. 2017 Aug 15;216(suppl_3):S458-S465. doi: 10.1093/infdis/jix121.

PMID:
28911041
25.

An Aptamer-Based Biosensor for the Azole Class of Antifungal Drugs.

Wiedman GR, Zhao Y, Mustaev A, Ping J, Vishnubhotla R, Johnson ATC, Perlin DS.

mSphere. 2017 Aug 23;2(4). pii: e00274-17. doi: 10.1128/mSphere.00274-17. eCollection 2017 Jul-Aug.

26.

Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.

Vella A, De Carolis E, Mello E, Perlin DS, Sanglard D, Sanguinetti M, Posteraro B.

Sci Rep. 2017 Aug 22;7(1):9099. doi: 10.1038/s41598-017-09329-4.

27.

The global problem of antifungal resistance: prevalence, mechanisms, and management.

Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A.

Lancet Infect Dis. 2017 Dec;17(12):e383-e392. doi: 10.1016/S1473-3099(17)30316-X. Epub 2017 Jul 31. Review.

PMID:
28774698
28.

Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model.

Zhao Y, Prideaux B, Nagasaki Y, Lee MH, Chen PY, Blanc L, Ho H, Clancy CJ, Nguyen MH, Dartois V, Perlin DS.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01009-17. doi: 10.1128/AAC.01009-17. Print 2017 Oct.

29.

De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance.

Jiménez-Ortigosa C, Perez WB, Angulo D, Borroto-Esoda K, Perlin DS.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00833-17. doi: 10.1128/AAC.00833-17. Print 2017 Sep.

30.

Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris.

Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS.

J Clin Microbiol. 2017 Aug;55(8):2445-2452. doi: 10.1128/JCM.00630-17. Epub 2017 May 24.

31.

Expression Dynamics of Innate Immunity in Influenza Virus-Infected Swine.

Montoya M, Foni E, Solórzano A, Razzuoli E, Baratelli M, Bilato D, Córdoba L, Del Burgo MAM, Martinez J, Martinez-Orellana P, Chiapponi C, Perlin DS, Del Real G, Amadori M.

Front Vet Sci. 2017 Apr 21;4:48. doi: 10.3389/fvets.2017.00048. eCollection 2017.

32.

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.

33.

Cryptococcus flips its lid - membrane phospholipid asymmetry modulates antifungal drug resistance and virulence.

Shor E, Wang Y, Perlin DS, Xue C.

Microb Cell. 2016 Aug 1;3(8):358-360. doi: 10.15698/mic2016.08.521.

34.

Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling.

Yang F, Zhang L, Wakabayashi H, Myers J, Jiang Y, Cao Y, Jimenez-Ortigosa C, Perlin DS, Rustchenko E.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00071-17. doi: 10.1128/AAC.00071-17. Print 2017 May. Erratum in: Antimicrob Agents Chemother. 2018 Mar 27;62(4):.

35.

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.

Dellière S, Healey K, Gits-Muselli M, Carrara B, Barbaro A, Guigue N, Lecefel C, Touratier S, Desnos-Ollivier M, Perlin DS, Bretagne S, Alanio A.

Front Microbiol. 2016 Dec 23;7:2038. doi: 10.3389/fmicb.2016.02038. eCollection 2016.

36.

Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters.

Vila-Farres X, Chu J, Inoyama D, Ternei MA, Lemetre C, Cohen LJ, Cho W, Reddy BV, Zebroski HA, Freundlich JS, Perlin DS, Brady SF.

J Am Chem Soc. 2017 Feb 1;139(4):1404-1407. doi: 10.1021/jacs.6b11861. Epub 2017 Jan 23.

PMID:
28055186
37.

Genetic Drivers of Multidrug Resistance in Candida glabrata.

Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS.

Front Microbiol. 2016 Dec 15;7:1995. doi: 10.3389/fmicb.2016.01995. eCollection 2016.

38.

Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.

Denning DW, Perlin DS, Muldoon EG, Colombo AL, Chakrabarti A, Richardson MD, Sorrell TC.

Emerg Infect Dis. 2017 Feb;23(2):177-183. doi: 10.3201/eid2302.152042. Epub 2017 Feb 15. Review.

39.

A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.

Zhou TC, Sankin AI, Porcelli SA, Perlin DS, Schoenberg MP, Zang X.

Urol Oncol. 2017 Jan;35(1):14-20. doi: 10.1016/j.urolonc.2016.10.004. Epub 2016 Nov 3. Review.

PMID:
27816403
40.

Discovery of MRSA active antibiotics using primary sequence from the human microbiome.

Chu J, Vila-Farres X, Inoyama D, Ternei M, Cohen LJ, Gordon EA, Reddy BV, Charlop-Powers Z, Zebroski HA, Gallardo-Macias R, Jaskowski M, Satish S, Park S, Perlin DS, Freundlich JS, Brady SF.

Nat Chem Biol. 2016 Dec;12(12):1004-1006. doi: 10.1038/nchembio.2207. Epub 2016 Oct 17.

41.

Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.

Zhao Y, Nagasaki Y, Kordalewska M, Press EG, Shields RK, Nguyen MH, Clancy CJ, Perlin DS.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6573-6577. doi: 10.1128/AAC.01574-16. Print 2016 Nov.

42.

Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients.

Zhao Y, Garnaud C, Brenier-Pinchart MP, Thiébaut-Bertrand A, Saint-Raymond C, Camara B, Hamidfar R, Cognet O, Maubon D, Cornet M, Perlin DS.

Front Microbiol. 2016 Jul 29;7:1164. doi: 10.3389/fmicb.2016.01164. eCollection 2016.

43.

CD101: a novel long-acting echinocandin.

Zhao Y, Perez WB, Jiménez-Ortigosa C, Hough G, Locke JB, Ong V, Bartizal K, Perlin DS.

Cell Microbiol. 2016 Sep;18(9):1308-16. doi: 10.1111/cmi.12640. Epub 2016 Jul 22.

44.

Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis.

Zhao Y, Paderu P, Railkar R, Douglas C, Iannone R, Shire N, Perlin DS.

Med Mycol. 2016 Nov 1;54(8):801-7. doi: 10.1093/mmy/myw043. Epub 2016 Jun 22.

PMID:
27335056
45.

Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.

Huang W, Liao G, Baker GM, Wang Y, Lau R, Paderu P, Perlin DS, Xue C.

MBio. 2016 May 10;7(3). pii: e00478-16. doi: 10.1128/mBio.00478-16.

46.

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, Kontoyiannis DP, Sanglard D, Taj-Aldeen SJ, Alexander BD, Jimenez-Ortigosa C, Shor E, Perlin DS.

Nat Commun. 2016 Mar 29;7:11128. doi: 10.1038/ncomms11128.

47.

Echinocandin Resistance in Candida.

Perlin DS.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S612-7. doi: 10.1093/cid/civ791.

48.

Carbohydrate-derived fulvic acid is a highly promising topical agent to enhance healing of wounds infected with drug-resistant pathogens.

Zhao Y, Paderu P, Delmas G, Dolgov E, Lee MH, Senter M, Park S, Leivers S, Perlin DS.

J Trauma Acute Care Surg. 2015 Oct;79(4 Suppl 2):S121-9. doi: 10.1097/TA.0000000000000737.

PMID:
26406424
49.

Cross-Species Infectivity of H3N8 Influenza Virus in an Experimental Infection in Swine.

Solórzano A, Foni E, Córdoba L, Baratelli M, Razzuoli E, Bilato D, Martín del Burgo MÁ, Perlin DS, Martínez J, Martínez-Orellana P, Fraile L, Chiapponi C, Amadori M, del Real G, Montoya M.

J Virol. 2015 Nov;89(22):11190-202. doi: 10.1128/JVI.01509-15. Epub 2015 Aug 26.

50.

Dose escalation studies with caspofungin against Candida glabrata.

Domán M, Kovács R, Perlin DS, Kardos G, Gesztelyi R, Juhász B, Bozó A, Majoros L.

J Med Microbiol. 2015 Sep;64(9):998-1007. doi: 10.1099/jmm.0.000116. Epub 2015 Jun 30.

Supplemental Content

Loading ...
Support Center